The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action - PubMed (original) (raw)
The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action
M L Smith et al. Eur J Cancer. 2000 Mar.
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit proliferation and induce apoptosis in human colorectal cancer cells in vitro. It remains unclear whether individual NSAIDs act by cyclooxygenase-2 (COX-2) inhibition and how NSAIDs exert their anti-proliferative effects. We investigated the effects of NS-398 (a selective COX-2 inhibitor), indomethacin (a non-selective COX inhibitor) and aspirin on four human colorectal cancer cell lines (HT29.Fu, HCA-7, SW480 and HCT116). NS-398 completely inhibited proliferation, induced G1 arrest and promoted apoptosis in COX-2-expressing cells (HT29.Fu and HCA-7). However, indomethacin had similar effects on all cells, regardless of COX-2 expression. NS-398 also had anti-proliferative activity on COX-2-negative cell lines (SW480 and HCT116). Aspirin inhibited proliferation of all cell lines but did not induce apoptosis. Indomethacin decreased beta-catenin protein expression in all cells (unlike NS-398 or aspirin). NSAIDs act on human colorectal cancer cells via different mechanisms. Decreased beta-catenin protein expression may mediate the anti-proliferative effects of indomethacin.
Similar articles
- The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
Dihlmann S, Siermann A, von Knebel Doeberitz M. Dihlmann S, et al. Oncogene. 2001 Feb 1;20(5):645-53. doi: 10.1038/sj.onc.1204123. Oncogene. 2001. PMID: 11313997 - Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines.
Hara A, Yoshimi N, Niwa M, Ino N, Mori H. Hara A, et al. Jpn J Cancer Res. 1997 Jun;88(6):600-4. doi: 10.1111/j.1349-7006.1997.tb00424.x. Jpn J Cancer Res. 1997. PMID: 9263538 Free PMC article. - The prevention of colorectal cancer by aspirin use.
Giovannucci E. Giovannucci E. Biomed Pharmacother. 1999 Aug;53(7):303-8. doi: 10.1016/S0753-3322(00)88500-5. Biomed Pharmacother. 1999. PMID: 10472428 Review. - Cyclooxygenase-2: a novel target for cancer chemotherapy?
Dempke W, Rie C, Grothey A, Schmoll HJ. Dempke W, et al. J Cancer Res Clin Oncol. 2001 Jul;127(7):411-7. doi: 10.1007/s004320000225. J Cancer Res Clin Oncol. 2001. PMID: 11469677 Review.
Cited by
- Recent Advancements in Refashioning of NSAIDs and their Derivatives as Anticancer Candidates.
Kassab AE, Gedawy EM. Kassab AE, et al. Curr Pharm Des. 2024;30(16):1217-1239. doi: 10.2174/0113816128304230240327044201. Curr Pharm Des. 2024. PMID: 38584541 Review. - Understanding the Wnt Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Feasible Key against Relapses.
Láinez-González D, Alonso-Aguado AB, Alonso-Dominguez JM. Láinez-González D, et al. Biology (Basel). 2023 May 5;12(5):683. doi: 10.3390/biology12050683. Biology (Basel). 2023. PMID: 37237497 Free PMC article. Review. - Non-steroidal anti-inflammatory drugs and biomarkers: A new paradigm in colorectal cancer.
Rashid G, Khan NA, Elsori D, Rehman A, Tanzeelah, Ahmad H, Maryam H, Rais A, Usmani MS, Babker AM, Kamal MA, Hafez W. Rashid G, et al. Front Med (Lausanne). 2023 Mar 6;10:1130710. doi: 10.3389/fmed.2023.1130710. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36950511 Free PMC article. Review. - Adenomas - Genetic factors in colorectal cancer prevention.
Witold K, Anna K, Maciej T, Jakub J. Witold K, et al. Rep Pract Oncol Radiother. 2018 Mar-Apr;23(2):75-83. doi: 10.1016/j.rpor.2017.12.003. Epub 2018 Feb 9. Rep Pract Oncol Radiother. 2018. PMID: 29463957 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous